Clinical Trial Update: Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating pembrolizumab in combination with stereotactic radiosurgery for selected brain metastases in patients with metastatic b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Metastatic Breast Cancer, Brain Metastases | Phase 1, Phase 2 | Status: RECRUITING